Multi‐Center Clinical Comparison of Combination Anorganic Bovine‐Derived Hydroxyapatite Matrix (ABM)/Cell Binding Peptide (P‐15) and ABM in Human Periodontal Osseous Defects. 6‐Month Results

Abstract

These results suggest that the use of the P-15 synthetic cell-binding peptide combined with ABM yields better clinical results than the ABM alone in intrabony periodontal defects.